Artificial intelligence (AI) is transforming medicine, and women's health is one of the areas with the potential to benefit. From faster diagnoses to personalized treatments, AI could eventually revolutionize the way diseases affecting women—such as breast cancer, endometriosis, or hormonal disorders—are detected and treated.
In Europe and globally, there are initiatives to integrate AI into healthcare systems. However, this integration presents significant challenges, ranging from data privacy to fairness in development. What is the real current impact of AI on women's health, and what can we truly expect in the future?
1. AI in the early detection of women's diseases.
One of AI's potential advancements in medicine is its ability to analyze large volumes of data, which could improve disease detection.
Breast cancer: Some AI algorithms are being evaluated for interpreting mammograms, with promising results in controlled research settings. However, in daily clinical practice, these systems still function primarily as support tools for human radiologists rather than replacements. In countries like the United Kingdom and Spain, these systems are in experimental implementation in some centers, but widespread adoption remains distant.
Endometriosis: This disease, which can take years to diagnose due to nonspecific symptoms, is being studied through AI models that analyze medical histories and symptoms. However, these models are still in preliminary stages of development and validation, with no routine clinical application yet.
2. Personalization of treatments with AI.
AI could eventually help design more specific treatments, although its real application remains limited.
Precision medicine in oncology: AI-assisted interpretation of tumor DNA is still in the research phase. However, therapeutic decision-making still fundamentally relies on medical judgment and established protocols. The promise of fully personalized treatments through AI remains largely a future aspiration.
Assisted reproduction: In European fertility clinics, AI-based embryo selection systems are still in the experimental phase. While research exists on algorithms that assess embryo viability, the evidence regarding their superiority over traditional selection methods is still preliminary and inconclusive. Most clinics continue to rely on traditional morphological criteria evaluated by experienced embryologists.
3. Monitoring and prevention with AI.
Smart devices and health applications offer some basic functionalities but come with significant limitations.
Menstrual and hormonal health apps: Applications like Flo or Clue use simple algorithms based on statistics to predict menstrual cycles. However, their ability to detect real medical conditions, such as polycystic ovary syndrome (PCOS), is extremely limited, and they should not be considered diagnostic tools but merely informational aids.
Monitoring devices for pregnancy and menopause: Smartwatches and wearable devices collect basic data, but their AI-based interpretation for detecting real medical complications is still in very early research stages. Currently, they do not replace conventional medical care.
4. Challenges and risks of AI in women's health.
The implementation of AI faces significant obstacles:
Privacy and data security: Medical information is highly sensitive. It is essential to ensure that the data collected by AI apps and systems is protected and not used without consent—an issue that has yet to be fully resolved.
Bias in algorithms: AI learns from historical data, but these datasets are often incomplete or unbalanced. For example, many medical studies have historically been based on male populations, which can lead to errors in diagnoses or treatments for women. A documented case in the United States showed that an AI system underestimated the severity of diseases in women because its training data was predominantly based on male patients.
5. Europe and the future of AI in women's health.
Europe is actively working on regulations and frameworks for AI in healthcare.
Investment in research: The European Union is funding AI research projects applied to medicine, with a focus on developing systems that can ultimately benefit all patients without discrimination.
Regulatory development: Unlike other regions, Europe is establishing legal frameworks to ensure that the future implementation of AI in healthcare is safe, transparent, and respectful of patient privacy.
Conclusion
While artificial intelligence holds promising potential for women's health, it is important to recognize that we are still in the very early stages of its development and real-world implementation. Most of the applications mentioned are still in experimental phases or have limited capabilities in everyday clinical practice.
However, in a rapidly evolving field, the key is to stay informed about advancements and be able to identify when AI can truly bring significant improvements. The speed at which these innovations are integrated will be crucial in positively transforming women's health in the coming years.
At Mater Clinic, we closely follow the evolution of these technologies to assess their scientific evidence and quickly adopt those that demonstrate real benefits. Our commitment is to stay at the forefront of innovation without compromising the human and personalized quality of our care.
If you have any questions or would like more information, contact us at care@mater.clinic, via WhatsApp at 645 096 548, or visit our website www.mater.clinic to book a free, personalized, and no-obligation consultation in Alicante or online.
.png){kind=small}
Commenti